RSS

nanoparticles

Researchers from the University of Illinois at Chicago have published an article in PLOS ONE demonstrating the potential of magnetic surgical cement as a vehicle for targeted drug delivery. more

News

A brief round-up of some of the developments in the industry including a step in the right direction for oral insulin and an overview of Alantra Pharma’s Fast 50 index… more

Opinion

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

A team of researchers at the University of Melbourne are developing nanoparticles that could potentially fight some of the most dangerous antibiotic resistant bacteria. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Inhaling nanoparticles may hold the key to non-invasive cardiac-targeting therapy, according to recent research published in Science Translational Medicine. more

News

Incorporating telehealth solutions into new drug delivery technologies like nanomedicines can potentially give pharmaceuticals the edge they need to win the fight against disease, says Alexander Myskiw, healthcare & life sciences practice, DataArt more

Analysis

A team, led by Dr Nicole Steinmetz from the Case Western Reserve University Schools of Engineering and Medicine in Cleveland, Ohio, has developed a nanoparticle drug delivery system (nanoDDS) for first-line treatment of Non-Hodgkin's lymphoma (NHL). more

News

An EU-funded project, Cupido, is researching the application of nanotechnologies in the cardiovascular field. Felicity Thomas explains more… more

Opinion

Researchers from Yale have found that changes to the surface properties of drug-loaded nanoparticles may improve specificity of drug delivery. The study was recently published in Nature Communications. more

News

Nemera is contributing to the EU-funded project Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts (Cupido), which is aimed at applying nanotechnologies to the cardiovascular field. more

News